Early changes in skin quality or inflammation may be noticeable within a few weeks, while more visible improvements in texture, firmness, or hair typically emerge over 8 to 12 weeks
This portfolio reflects Lillys strategy of pursuing multiple complementary approaches to metabolic disease: Tirzepatide : Dual GIP/GLP-1 agonist (approved, injectable) Retatrutide : Triple GIP/GLP-1/glucagon agonist (Phase 3, injectable) Orforglipron : Oral GLP-1R agonist (Phase 3, oral) If retatrutide is approved, it could be positioned as a more potent option for patients requiring greater weight loss or those with MASLD, while tirzepatide and orforglipron serve other patient segments
GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) are both important hormones released after eating to help regulate your insulin levels, but they have some key differences
While more research is needed, the current evidence supports B12 as a treatment for nerve pain
The colour of such lesions varies from red-blue to blue-black and is closely related to the degradation of hemoglobin in the extravascular spaces
Front Mol Neurosci 18:1518868